Roy Golan Email & Phone Number
@biosight-pharma.com
LinkedIn matched
Who is Roy Golan? Overview
A concise factual answer block for searchers comparing this professional profile.
Roy Golan is listed as Chief Financial Officer at LIVEKIDNEY.BIO, a company with 5 employees, based in Israel, Israel, Israel. AeroLeads shows a work email signal at biosight-pharma.com and a matched LinkedIn profile for Roy Golan.
Roy Golan previously worked as Financial Advisor at Biotech/Medtech/Hightech Companies and Board Member at Neurosense Therapeutics. Roy Golan holds Legislate Law Master (Llm) Degree, Law from Bar-Ilan University.
Email format at LIVEKIDNEY.BIO
This section adds company-level context without repeating Roy Golan's masked contact details.
AeroLeads found 1 current-domain work email signal for Roy Golan. Compare company email patterns before reaching out.
About Roy Golan
A registered CPA with a broad experience in aspects of Nasdaq, IPOs & M&As .Managed financial roles in small and medium sized Pharmaceutical, Biotech, High-Tech and Medical Device companies, both private and public. Until June 2024, served as the Chief Financial Officer of Ayala Pharmaceuticals Inc. (OTC: ADXS) and as an Executive VP and CFO of BioSight Ltd. Led the merger between Biosight and Ayala Pharmaceuticals Inc. and played a major role in the Asset deal between Ayala Pharmaceuticals Inc. and Immunome (Nasdaq: IMNM).Previously served as President & CFO of Exalenz Ltd., a diagnostics company traded on TASE, later acquired by Meridian Bioscience, Inc. (VIVO). Previous to that, served as NDRM's CFO, had a pivotal role in their successful IPO, two Follow-On Offerings on Nasdaq and NDRM's acquisition by Mitsubishi Tanabe Pharmaceutical Corporation for a total of US$1.1 billion.
Listed skills include Managerial Finance, Due Diligence, Finance, Accounting, and 15 others.
Roy Golan's current company
Company context helps verify the profile and gives searchers a useful next step.
Roy Golan work experience
A career timeline built from the work history available for this profile.
Financial Advisor
Current
Board Member
CurrentChief Financial Officer
Ayala is a clinical-stage oncology company founded in November 2017 after acquiring an exclusive, worldwide license to our product candidates AL101 and AL102 from Bristol-Myers Squibb (BMS). On October 2023, Biosight Ltd. merged with Ayala Pharmaceuticals Inc. Led the merger between Biosight and Ayala Pharmaceuticals Inc. and played a major role in the.
Executive Vice President & Cfo
Biosight is a private Phase 2 clinical stage biotech company, developing innovative therapeutics for hematological malignancies and disorders. Biosight’s lead product, BST-236 (INN aspacytarabine), is an innovative proprietary anti-metabolite designed to enable high-dose chemotherapy with reduced systemic toxicity.
President & Chief Financial Officer
Exalenz Bioscience (TASE: EXEN) is a global, commercial-stage diagnostics company using its BreathID® technology platform to improve patient care by providing advanced, innovative breath-based tests in the fields of gastroenterology and hepatology.The company is traded on the Tel-Aviv Stock Exchange.
Chief Financial Officer
Neuroderm (NASDAQ: NDRM) is a clinical-stage pharmaceutical company developing drugs for central nervous system (CNS) diseases. As NDRM's CFO, had a pivotal role in our successful IPO, two Follow-On Offerings on Nasdaq (raising over $200M) and NDRM's recent acquisition by Mitsubishi Tanabe Pharmaceutical Corporation for a total of US$1.1 billion.
Vice President Finance
Board Member At Neuroderm Inc.
Vp Finance
Managed the Finance, Accounting, Legal,HR & Administrative departments.
Corporate Controller
- Pivotal role in all corporate financial matters.
- Pivotal role in filing company on NASDAQ.
- Lead role in implementing Sarbanes-Oxley, while serving as “SOX Champion”.
Roy Golan education
Legislate Law Master (Llm) Degree, Law
B.A., Business And Accounting
Education record
Frequently asked questions about Roy Golan
Quick answers generated from the profile data available on this page.
What company does Roy Golan work for?
Roy Golan works for LIVEKIDNEY.BIO.
What is Roy Golan's role at LIVEKIDNEY.BIO?
Roy Golan is listed as Chief Financial Officer at LIVEKIDNEY.BIO.
What is Roy Golan's email address?
AeroLeads has found 1 work email signal at @biosight-pharma.com for Roy Golan at LIVEKIDNEY.BIO.
Where is Roy Golan based?
Roy Golan is based in Israel, Israel, Israel while working with LIVEKIDNEY.BIO.
What companies has Roy Golan worked for?
Roy Golan has worked for Livekidney.Bio, Biotech/Medtech/Hightech Companies, Neurosense Therapeutics, Ayala Pharmaceuticals, and Biosight Ltd..
How can I contact Roy Golan?
You can use AeroLeads to view verified contact signals for Roy Golan at LIVEKIDNEY.BIO, including work email, phone, and LinkedIn data when available.
What schools did Roy Golan attend?
Roy Golan holds Legislate Law Master (Llm) Degree, Law from Bar-Ilan University.
What skills is Roy Golan known for?
Roy Golan is listed with skills including Managerial Finance, Due Diligence, Finance, Accounting, Start Ups, Management, Corporate Finance, and Mergers And Acquisitions.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial